Meredith Manning sold $2.9M of Soleno Therapeutics (SLNO)

Executed Mar 27 2025, disclosed Mar 31 2025, 4 days later.

Value, as filed

$2.9M

43,080 sh across 4 lots

Executed

Mar 27 2025

the trade date, as filed

Disclosed

Mar 31 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

MM Meredith Manning Chief Commercial Officer profile →

Meredith Manning (Chief Commercial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in SLNO. The largest single filing was $146K of SLNO (4,864 sh × $30.04, as filed), executed Mar 27.

The name

SLNO SLNO SLNO · 19 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Meredith Manning in SLNO

SLNOSALE SOLENO THERAPEUTICS INC $146K
4,864 sh × $30.04
Exec Mar 27
Filed Mar 31 · 5:30 PM ET